|
|
|
|
|
by icegreentea2
884 days ago
|
|
Antibiotics are consumables - in a B2B context (it's a medical service provider who is paying the subscription fee), antibiotics are basically a subscription. Many (most?) diagnostic devices have consumables which is where companies make the bulk of their revenue. Failing that, service contracts are usually in place to lock in some sort of sustained reoccuring revenue. There is no fundamental reason why a company couldn't do your proposed model, but upgrades are definitely challenging - if you make your model better, or you improve your hardware, or basically do anything that isn't a bug fix or an ancillary upgrade (like I dunno, you made the thing boot up 25% faster), will likely require additional testing and approval from the FDA. |
|